Biktarvy, formally known as bictegravir, is a effective single-tablet treatment for controlling HIV infection. This drug integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to copy within the body, remarkably decreasing the viral quantity. For many indiv